Pharma Two B

Pharma Two B is a pioneering biotechnology research company dedicated to enhancing the quality of life for patients through the development of innovative combination products. Leveraging years of expertise, Pharma Two B identifies and characterizes potential drug combinations, offering high therapeutic effects with improved safety profiles. The company’s commitment to addressing unmet medical needs is reflected in its development of clinically meaningful and safe added-value combination products.

Based in Rehovot, at Prof. Haim Pekeris St 3, Rehovot, 7670203, IL, Pharma Two B focuses on novel, synergistic combinations based on previously approved drugs. Their lead investigational product, P2B001, has successfully completed both Phase IIb and Phase III studies for the treatment of early Parkinson’s Disease (PD), showcasing the company’s ability to advance promising treatments through clinical stages.

Pharma Two B continues to innovate and expand its research efforts, striving to bring groundbreaking solutions to the pharmaceutical landscape. For more information, please visit their website. We invite the management team at Pharma Two B to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development and reach a wider audience.